Skip to content
value.today

Click Diagnostics, Inc.

🇺🇸 Menlo Park, California, USABiotechnologyFounded 2012
Total raised
$235 M
4 rounds on record
Latest round
$109 M
Feb 2022
First round on record
Oct 2015
Today
Private
No later event on record

Funding rounds

4 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Click Diagnostics, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Feb 2022$109 MNo. 4$50 to $250 million

Click Diagnostics, Inc.: Raise no. 4, Feb 2022

Investors in this round

45 investors had bought by the notice of Mar 1, 2022: 45 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$109 M of $156 M offered; $48 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, other: Series E Preferred Stock and Common Stock issuable upon conversion
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Adam de la Zerda · Executive Officer, Director
  • John Kuo · Executive Officer
  • Mark Ibison · Executive Officer
  • Amit M. Shah · Director
  • Eric E. Moessinger · Director
  • Jerome Behar · Director
  • Scott E. Mendel · Director
  • Shlomo Melmed · Director
  • Terri Bresenham · Director
  • Thomas M. Prescott · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Adam de la Zerda, Chief Executive Officer. Source: SEC Form D, newest notice filed Mar 1, 2022. Read the notice at the SEC.

equitySEC
Apr 2019$101 MNo. 3$50 to $250 million

Click Diagnostics, Inc.: Raise no. 3, Apr 2019

Investors in this round

101 investors had bought by the notice of May 14, 2019: 101 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$101 M of $134 M offered; $33 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Adam De La Zerda · Executive Officer, Director
  • Ajit Singh · Executive Officer, Director
  • Gregory Loney · Executive Officer
  • David Engman · Director
  • Jerome Behar · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Ajit Singh, President. Source: SEC Form D, newest notice filed May 14, 2019. Read the notice at the SEC.

equitySEC
Jan 2018$10 MNo. 2$2 to $10 million

Click Diagnostics, Inc.: Raise no. 2, Jan 2018

Investors in this round

21 investors had bought by the notice of Jan 19, 2018: 21 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$10 M of $15 M offered; $5 M still to sell
Smallest investment taken
no minimum stated
What was sold
debt, options or other rights to buy securities
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Adam De La Zerda · Executive Officer, Director
  • Ajit Singh · Executive Officer, Director
  • Jerome Behar · Director
  • Steven Rosston · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Adam de la Zerda, Founder, CEO. Source: SEC Form D, newest notice filed Jan 19, 2018. Read the notice at the SEC.

debt, optionsSEC
Oct 2015$16 MNo. 1$10 to $50 million

Click Diagnostics, Inc.: Raise no. 1, Oct 2015

Investors in this round

30 investors had bought by the notice of Nov 5, 2015: 30 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$16 M of $16 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Ajit Singh · Executive Officer, Director
  • Adam De La Zerda · Director, Promoter
  • Jerome Behar · Director
  • Steven Rosston · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Ajit Singh, Ceo/president. Source: SEC Form D, newest notice filed Nov 5, 2015. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Click Diagnostics, Inc. chose not to state its revenue in its newest notice of a funding round (Mar 2022).

    SEC Form D · Mar 2022

  • The industry group it chose in its notices: Biotechnology.

    SEC Form D · Mar 2022

That is all the official record says: Click Diagnostics, Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Click Diagnostics, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 4 rounds above had up to 101 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Click Diagnostics, Inc.
NameRoleNamed in
Adam de la ZerdaExecutive officerMar 2022
John KuoExecutive officerMar 2022
Mark IbisonExecutive officerMar 2022
Adam De La ZerdaExecutive officerMay 2019
Ajit SinghExecutive officerMay 2019
Gregory LoneyExecutive officerMay 2019
Adam de la ZerdaDirectorMar 2022
Amit M. ShahDirectorMar 2022
Eric E. MoessingerDirectorMar 2022
Jerome BeharDirectorMar 2022
Scott E. MendelDirectorMar 2022
Shlomo MelmedDirectorMar 2022
Terri BresenhamDirectorMar 2022
Thomas M. PrescottDirectorMar 2022
Adam De La ZerdaDirectorMay 2019
Ajit SinghDirectorMay 2019
David EngmanDirectorMay 2019
Steven RosstonDirectorJan 2018
Adam De La ZerdaPromoterNov 2015